Partnership powers up WCG Academy for online clinical learning
By Mia Burns
As a provider of regulatory and ethical review services for human research, WIRB-Copernicus Group has announced a partnership with UL Quality, Compliance and Learning to bring unsurpassed educational opportunities to clinical research professionals. The collaboration, WCG Academy, will provide industry, investigators, and other researchers a unique platform with focused, high-value education that is easily tracked across multiple studies.
WCG Academy will use UL’s cloud-based platform, ComplianceWire to provide clients effective online learning solutions aligned with their needs and with specific study protocols and requirements. As a result of the power that the partnership will possess, and through WCG Academy, WIRB-Copernicus Group continues to expand its offered services to assist clients in streamlining and enriching the clinical research process.
WCG Academy is a knowledge portal that will have the most current clinical knowledge related to Good Clinical Practice and Research Ethics for human research and laboratory animal welfare. The online clinical library will include more than 100 courses which are part of UL’s extensive course offerings provided to ORA-U, the FDA’s virtual university, under a unique partnership that has been in place with the FDA since 1999.
In addition, WCG Academy provides site personnel training on FDA requirements, specific protocols, research updates, best clinical practices, and benchmarked performance. Assuring continuity of understanding and competency among those who design, manage, and conduct clinical trials is a requisite to assuring that human subjects are protected and the scientific objectives of clinical research are satisfied.
“It is a quite a powerful combination of courses,” says Donald A. Deieso, Ph.D., executive chairman of the WIRB-Copernicus Group. “We will keep transcripts for the individuals who take part in the WCG Academy program.”
Dr. Deieso also told R&D Business Pharma Connect that quizzes and competency tests will ensure that personnel have a deep understanding about the knowledge that is being transferred about a protocol. He officially announced the creation of WCG Academy and the partnership with UL during the 49th Annual Meeting of the Drug Information Association in Boston, Mass., in late June.
“We seek to go much deeper to create strategic partnerships with our clients,” Dr. Deieso told R&D Business Pharma Connect. “The independent review board is just one of the whole series of things that we do to ensure not only that human subjects are protected, but also that those doing the clinical research have a requisite knowledge and understanding such that they perform consistently with the sponsor and CRO requirements, ethical requirements, and regulatory requirements, all while trying to bring as much digitalization to this field as the 21st century can demand,” he says.
The WCG Academy adds a vital new dimension to the WIRB-Copernicus Group’s network of investigators and institutions. WCG Academy will increase the efficiency and reduce study start-up time for contract research organizations and trial sponsors.
“We seek to go much deeper to create strategic partnerships with our clients,” Dr. Deieso told R&D Business Pharma Connect. “The IRB is just one of the whole series of things that we do to ensure first that human subjects are protected, that those doing the clinical research have a requisite knowledge and understanding such that they perform consistently with the sponsor and CRO requirements, ethical requirements, regulatory requirements, and in short trying to bring as much digitalization to this field that the 21st century can demand,” he says.
Posted: August 2013